{"id":"https://openalex.org/W4393988945","doi":"https://doi.org/10.1158/1538-7445.am2024-ct059","title":"Abstract CT059: Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas","display_name":"Abstract CT059: Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas","publication_year":2024,"publication_date":"2024-04-05","ids":{"openalex":"https://openalex.org/W4393988945","doi":"https://doi.org/10.1158/1538-7445.am2024-ct059"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-ct059","doi":"https://doi.org/10.1158/1538-7445.am2024-ct059","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-ct059","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091098703","display_name":"Brian Andrew Van Tine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Andrew Van Tine","raw_affiliation_strings":["1Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102709933","display_name":"Christopher T. Chen","orcid":"https://orcid.org/0000-0001-8962-3527","observed_orcids":["https://orcid.org/0000-0001-8962-3527","https://orcid.org/0000-0001-8911-0203","https://orcid.org/0000-0002-6527-7022"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher T. Chen","raw_affiliation_strings":["2Stanford University School of Medicine, Palo Alto, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Stanford University School of Medicine, Palo Alto, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006299989","display_name":"V\u00edctor Moreno","orcid":"https://orcid.org/0000-0001-6099-4236","observed_orcids":["https://orcid.org/0000-0001-6099-4236"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Victor Moreno","raw_affiliation_strings":["3START Madrid-FJD, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3START Madrid-FJD, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;","institution_ids":["https://openalex.org/I4210129357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068498659","display_name":"Elizabeth J. Davis","orcid":"https://orcid.org/0000-0001-7626-2435","observed_orcids":["https://orcid.org/0000-0001-7626-2435"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Davis","raw_affiliation_strings":["4Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria J. de Miguel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137474","display_name":"Hospital Universitario HM Sanchinarro","ror":"https://ror.org/04jep6391","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122338","https://openalex.org/I4210137474"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria J. de Miguel","raw_affiliation_strings":["5START Madrid-CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5START Madrid-CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain;","institution_ids":["https://openalex.org/I4210137474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060949051","display_name":"Anto\u00eene Italiano","orcid":"https://orcid.org/0000-0002-8540-5351","observed_orcids":["https://orcid.org/0000-0002-8540-5351"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Italiano","raw_affiliation_strings":["6Bergoni\u00e9 Institute, Bordeaux, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bergoni\u00e9 Institute, Bordeaux, France;","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108780490","display_name":"Esma Sa\u00e2da-Bouzid","orcid":"https://orcid.org/0009-0002-3924-286X","observed_orcids":["https://orcid.org/0009-0002-3924-286X","https://orcid.org/0000-0002-2156-9162"]},"institutions":[{"id":"https://openalex.org/I201841394","display_name":"Universit\u00e9 C\u00f4te d'Azur","ror":"https://ror.org/019tgvf94","country_code":"FR","type":"education","lineage":["https://openalex.org/I201841394"]},{"id":"https://openalex.org/I4210151846","display_name":"Centre Antoine Lacassagne","ror":"https://ror.org/05hmfw828","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210151846"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Esma Saada-Bouzid","raw_affiliation_strings":["7Universit\u00e9 Cote d'Azur, Centre Antoine Lacassagne, Nice, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Universit\u00e9 Cote d'Azur, Centre Antoine Lacassagne, Nice, France;","institution_ids":["https://openalex.org/I201841394","https://openalex.org/I4210151846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089777560","display_name":"Mohammed M. Milhem","orcid":"https://orcid.org/0000-0003-4663-6824","observed_orcids":["https://orcid.org/0000-0003-4663-6824"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Milhem","raw_affiliation_strings":["8University of Iowa, Iowa City, IA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8University of Iowa, Iowa City, IA;","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009531132","display_name":"Claudia Mar\u00eda Valverde","orcid":"https://orcid.org/0000-0003-4107-8616","observed_orcids":["https://orcid.org/0000-0003-4107-8616"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Claudia Valverde","raw_affiliation_strings":["9Vall d'Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Vall d'Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073906112","display_name":"Sant P. Chawla","orcid":"https://orcid.org/0000-0002-9522-6744","observed_orcids":["https://orcid.org/0000-0002-9522-6744"]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sant P. Chawla","raw_affiliation_strings":["10Sarcoma Oncology Research Center, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Sarcoma Oncology Research Center, Santa Monica, CA;","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090621600","display_name":"Abdul Rafeh Naqash","orcid":"https://orcid.org/0000-0001-7622-720X","observed_orcids":["https://orcid.org/0000-0001-7622-720X"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul Rafeh Naqash","raw_affiliation_strings":["11Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK;","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033090749","display_name":"Louise Carter","orcid":"https://orcid.org/0000-0002-9854-2304","observed_orcids":["https://orcid.org/0000-0002-9854-2304"]},"institutions":[{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Louise Carter","raw_affiliation_strings":["12The Christie NHS Foundation Trust, Manchester, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12The Christie NHS Foundation Trust, Manchester, United Kingdom;","institution_ids":["https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048969933","display_name":"Robin L. Jones","orcid":"https://orcid.org/0000-0003-4173-3844","observed_orcids":["https://orcid.org/0000-0003-4173-3844"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robin Jones","raw_affiliation_strings":["13Royal Marsden NHS Foundation Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Royal Marsden NHS Foundation Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043104677","display_name":"Ilaria Conti","orcid":"https://orcid.org/0000-0002-7276-3168","observed_orcids":["https://orcid.org/0000-0002-7276-3168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilaria Conti","raw_affiliation_strings":["14ADC Therapeutics, New Providence, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14ADC Therapeutics, New Providence, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113164025","display_name":"Joe Boni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joe Boni","raw_affiliation_strings":["14ADC Therapeutics, New Providence, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14ADC Therapeutics, New Providence, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068778166","display_name":"Karin Havenith","orcid":"https://orcid.org/0000-0002-0610-4228","observed_orcids":["https://orcid.org/0000-0002-0610-4228"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Havenith","raw_affiliation_strings":["15ADC Therapeutics, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15ADC Therapeutics, London, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027325364","display_name":"Yvan LeBruchec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115358","display_name":"Adc Therapeutics (Switzerland)","ror":"https://ror.org/029g9r930","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210115358"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Yvan LeBruchec","raw_affiliation_strings":["16ADC Therapeutics, \u00c9palinges, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16ADC Therapeutics, \u00c9palinges, Switzerland;","institution_ids":["https://openalex.org/I4210115358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075250803","display_name":"Serafino Pantano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115358","display_name":"Adc Therapeutics (Switzerland)","ror":"https://ror.org/029g9r930","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210115358"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Serafino Pantano","raw_affiliation_strings":["16ADC Therapeutics, \u00c9palinges, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16ADC Therapeutics, \u00c9palinges, Switzerland;","institution_ids":["https://openalex.org/I4210115358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Yves Blay","raw_affiliation_strings":["17Centre L\u00e9on-B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Centre L\u00e9on-B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"7_Supplement","first_page":"CT059","last_page":"CT059"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axl-receptor-tyrosine-kinase","display_name":"AXL receptor tyrosine kinase","score":0.906000018119812},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9760000109672546},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/bone-sarcoma","display_name":"bone sarcoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9129999876022339},{"id":"https://openalex.org/keywords/palmar-plantar-erythrodysesthesia-syndrome","display_name":"palmar-plantar erythrodysesthesia syndrome","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C2909636867","wikidata":"https://www.wikidata.org/wiki/Q56014469","display_name":"Bone Sarcoma","level":3,"score":0.7169369459152222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6832520961761475},{"id":"https://openalex.org/C136948725","wikidata":"https://www.wikidata.org/wiki/Q1458306","display_name":"Soft tissue","level":2,"score":0.6219092011451721},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5008306503295898},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4718998372554779},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.2676376402378082}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-ct059","doi":"https://doi.org/10.1158/1538-7445.am2024-ct059","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-ct059","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7222618238","https://openalex.org/W2978613778","https://openalex.org/W3031675467","https://openalex.org/W4387826614","https://openalex.org/W7162523655","https://openalex.org/W2135433020","https://openalex.org/W1876442089","https://openalex.org/W7099136989","https://openalex.org/W4283833692","https://openalex.org/W2528160778"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"AXL":[2,163,361],"is":[3,22,110],"a":[4,27,33,111,136,166,323,431],"cell":[5],"surface":[6],"receptor":[7],"tyrosine":[8],"kinase":[9],"widely":[10],"expressed":[11],"in":[12,45,59,63,73,83,97,135,178,216,255,294,363,430,448,509],"solid":[13],"tumors":[14],"(ST),":[15],"including":[16,322],"sarcomas.":[17],"ADCT-601":[18],"(Mipasetamab":[19],"uzoptirine;":[20],"Mipa)":[21],"an":[23],"antibody-drug":[24],"conjugate":[25],"comprising":[26],"humanized":[28],"anti-AXL":[29],"antibody":[30],"conjugated":[31],"via":[32],"cleavable":[34],"linker":[35],"to":[36,379,406,413,427,439,441],"SG3199":[37],"(pyrrolobenzodiazepine":[38],"dimer":[39],"cytotoxin).":[40],"Mipa":[41,96,120,126,414,444],"demonstrated":[42],"antitumor":[43],"activity":[44,58,418],"pre-clinical":[46],"mice":[47],"models":[48],"of":[49,95,105,119,143,169,173,409,521],"sarcoma,":[50],"adrenocortical":[51],"carcinoma":[52],"and":[53,56,78,93,156,186,203,225,245,279,284,344,393,415,447,514,536],"pancreatic":[54],"cancer,":[55],"clinical":[57,71],"ST":[60],"patients":[61,149,510],"(pts)":[62],"its":[64],"first-in-human":[65],"trial.":[66],"Here,":[67],"we":[68],"report":[69],"initial":[70],"data":[72,374,395],"pts":[74,98,196,201,207,218,233,237,242,248,257,268,308,320,330,335,350],"with":[75,86,99,165,377,385,451,511],"advanced":[76,512],"bone":[77,159,513],"soft":[79,152,515],"tissue":[80,153,516],"sarcomas":[81,517],"treated":[82],"dose":[84,116,133,138,181,271,299,426,433,449,507],"escalation":[85,139,450,508],"Mipa.":[87],"Objective:":[88],"To":[89],"characterize":[90],"the":[91,407,416,424,522],"safety":[92],"tolerability":[94],"sarcoma":[100,148,154,307,365],"indications":[101],"who":[102],"exhausted":[103],"standard":[104],"care":[106],"therapy.":[107],"Method:":[108],"This":[109],"phase":[112],"1b,":[113],"open-label,":[114],"dose-escalation,":[115],"expansion":[117],"study":[118,437],"(NCT05389462;":[121],"EudraCT:":[122],"2021-00566-18).":[123],"Pts":[124],"received":[125],"every":[127],"3":[128,157,170,252,262,281],"weeks":[129],"(Q3W)":[130],"at":[131,282,341],"escalating":[132],"levels,":[134],"3+3":[137],"design.":[140],"Results:":[141],"As":[142],"04":[144],"December":[145],"2023,":[146],"18":[147],"(15":[150],"[83%],":[151],"[STS]":[155],"[17%]":[158],"sarcoma),":[160],"unselected":[161],"for":[162,189,525],"expression,":[164],"median":[167],"number":[168],"prior":[171],"lines":[172],"therapy":[174],"(1-10),":[175],"were":[176,192,214,228,253,264,274],"enrolled":[177],"4":[179],"different":[180],"cohorts:":[182],"7.5mg,":[183,342],"11mg,":[184],"13mg":[185,285],"15mg.":[187],"Reasons":[188],"treatment":[190],"discontinuation":[191],"disease":[193,327,333],"progression":[194],"(10":[195],"[55.6%]),":[197],"adverse":[198,211],"events":[199,212],"(3":[200],"[16.7%])":[202],"consent":[204],"withdrawal":[205],"(2":[206,267,319],"[11.1%]).":[208,269],"Treatment":[209],"emergent":[210],"(TEAE)":[213],"seen":[215,254],"17":[217,306],"(94.4%).":[219],"Most":[220,259],"common":[221,260],"TEAE":[222,410],"(all":[223],"grades":[224],"relationship":[226],"[\u226520%])":[227],"palmar-plantar":[229],"erythrodysesthesia":[230],"syndrome":[231],"(7":[232,334],"[38.9%]);":[234],"anemia":[235],"(6":[236],"[33.3%]);":[238],"rash":[239],"maculopapular":[240],"(5":[241],"[27.8%]);":[243],"cheilitis":[244,276],"constipation":[246],"(4":[247],"each":[249],"[22.2%]).":[250],"TEAE\u2265grade":[251,261],"9":[256],"(50%).":[258],"(\u226510%)":[263],"GGT":[265],"increase":[266],"Two":[270],"limiting":[272],"toxicities":[273],"seen:":[275],"grade":[277,280],"2":[278,532],"15mg":[283,420],"respectively.":[286],"Cutaneous":[287],"reactions,":[288],"all":[289,364],"grades,":[290],"are":[291],"more":[292],"prominent":[293],"higher":[295],"doses.":[296],"Maximum":[297],"tolerated":[298],"(MTD)":[300],"has":[301],"not":[302,353,403],"been":[303],"established.":[304,404],"In":[305],"evaluable":[309],"per":[310],"RECISTv1.1,":[311],"best":[312],"overall":[313],"response":[314,317],"was":[315,339,402,421],"partial":[316],"(PR)":[318],"[11.8%]),":[321],"confirmed":[324],"PR;":[325],"stable":[326],"(SD)":[328],"(8":[329],"[47.1%]);":[331],"progressive":[332],"[41.2%]).":[336],"Tumor":[337],"reductions":[338],"observed":[340],"11mg":[343],"13mg.":[345],"By":[346],"week":[347],"12,":[348],"6/17":[349],"(35.3%)":[351],"did":[352],"demonstrate":[354],"PD":[355],".":[356],"Initial":[357,371],"IHC":[358],"staining":[359],"showed":[360],"expression":[362],"baseline":[366],"biopsies":[367],"tested":[368,429],"so":[369],"far.":[370],"pharmacokinetic":[372],"(PK)":[373],"indicate":[375],"exposures":[376],"moderate":[378],"marked":[380],"interpatient":[381],"variability;":[382],"rapid":[383],"clearance":[384],"no":[386],"accumulation":[387],"by":[388],"Cycle":[389],"2.":[390],"Updated":[391],"biomarkers":[392],"PK":[394],"will":[396],"be":[397,428],"presented.":[398],"Conclusion:":[399],"The":[400,436],"MTD":[401],"Due":[405],"incidence":[408],"judged":[411],"related":[412],"preliminary":[417],"observed,":[419],"selected":[422],"as":[423],"highest":[425],"fixed":[432],"Q3W":[434],"regimen.":[435],"continues":[438],"enroll":[440],"further":[442],"optimize":[443],"dosing":[445],"regimen":[446],"gemcitabine.":[452],"Citation":[453],"Format:":[454],"Brian":[455],"Andrew":[456],"Van":[457],"Tine,":[458],"Christopher":[459],"T.":[460],"Chen,":[461],"Victor":[462],"Moreno,":[463],"Elizabeth":[464],"J.":[465,468],"Davis,":[466],"Maria":[467],"de":[469],"Miguel,":[470],"Antoine":[471],"Italiano,":[472],"Esma":[473],"Saada-Bouzid,":[474],"Mohammed":[475],"Milhem,":[476],"Claudia":[477],"Valverde,":[478],"Sant":[479],"P.":[480],"Chawla,":[481],"Abdul":[482],"Rafeh":[483],"Naqash,":[484],"Louise":[485],"Carter,":[486],"Robin":[487],"Jones,":[488],"Ilaria":[489],"Conti,":[490],"Joe":[491],"Boni,":[492],"Karin":[493],"Havenith,":[494],"Yvan":[495],"LeBruchec,":[496],"Serafino":[497],"Pantano,":[498],"Jean-Yves":[499],"Blay.":[500],"Phase":[501],"1b":[502],"trial":[503],"Mipasetamab":[504],"Uzoptirine":[505],"(ADCT-601-102)":[506],"[abstract].":[518],"In:":[519],"Proceedings":[520],"American":[523],"Association":[524],"Cancer":[526,548],"Research":[527],"Annual":[528],"Meeting":[529],"2024;":[530],"Part":[531],"(Late-Breaking,":[533],"Clinical":[534],"Trial,":[535],"Invited":[537],"Abstracts);":[538],"2024":[539],"Apr":[540],"5-10;":[541],"San":[542],"Diego,":[543],"CA.":[544],"Philadelphia":[545],"(PA):":[546],"AACR;":[547],"Res":[549],"2024;84(7_Suppl):Abstract":[550],"nr":[551],"CT059.":[552]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-04-06T00:00:00"}